CNPY2 and α‐SMA expression were notably upregulated in IPF lung fibroblast and reduced after hsa‐miR‐30a‐3p treatment (Figure S5A, Supporting Information). The gene discussed is ACTA1; the disease is idiopathic pulmonary fibrosis.